Vaccinology in sub-Saharan Africa
We undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field . We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-10-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/5/e001363.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846126384099885056 |
|---|---|
| author | Helen Rees Jennifer Moïsi Shabir Ahmed Madhi |
| author_facet | Helen Rees Jennifer Moïsi Shabir Ahmed Madhi |
| author_sort | Helen Rees |
| collection | DOAJ |
| description | We undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field . We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites, searched the scientific literature and analysed donor databases as part of our mapping exercise. We found that (1) few vaccinology training programmes are available in the region; (2) vaccinology research sites are numerous but unevenly distributed across countries and subregions and of widely varying capacity; (3) donor funding favours HIV, tuberculosis and malaria vaccine development over other high-burden diseases; (4) lack of vaccine design, manufacturing and regulatory capacity slows the progress of new vaccines through the research and development pipeline and (5) vaccine implementation research garners limited support. Regional efforts to strengthen African vaccinology expertise should develop advanced vaccinology training programmes, support clinical trial and implementation research sites in geographic areas with limited capacity and conduct multidisciplinary research to help design, license and roll out new vaccines. |
| format | Article |
| id | doaj-art-d7d6f51e553d438b84bf65a2b4cc94d0 |
| institution | Kabale University |
| issn | 2059-7908 |
| language | English |
| publishDate | 2019-10-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Global Health |
| spelling | doaj-art-d7d6f51e553d438b84bf65a2b4cc94d02024-12-12T21:10:10ZengBMJ Publishing GroupBMJ Global Health2059-79082019-10-014510.1136/bmjgh-2018-001363Vaccinology in sub-Saharan AfricaHelen Rees0Jennifer Moïsi1Shabir Ahmed Madhi2Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South AfricaIndependent Consultant, Paris, FranceDepartment of Science and Technology/National Research Foundation: South African Research Chair Initiative: Vaccine Preventable Diseases—Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, Gauteng, South AfricaWe undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field . We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites, searched the scientific literature and analysed donor databases as part of our mapping exercise. We found that (1) few vaccinology training programmes are available in the region; (2) vaccinology research sites are numerous but unevenly distributed across countries and subregions and of widely varying capacity; (3) donor funding favours HIV, tuberculosis and malaria vaccine development over other high-burden diseases; (4) lack of vaccine design, manufacturing and regulatory capacity slows the progress of new vaccines through the research and development pipeline and (5) vaccine implementation research garners limited support. Regional efforts to strengthen African vaccinology expertise should develop advanced vaccinology training programmes, support clinical trial and implementation research sites in geographic areas with limited capacity and conduct multidisciplinary research to help design, license and roll out new vaccines.https://gh.bmj.com/content/4/5/e001363.full |
| spellingShingle | Helen Rees Jennifer Moïsi Shabir Ahmed Madhi Vaccinology in sub-Saharan Africa BMJ Global Health |
| title | Vaccinology in sub-Saharan Africa |
| title_full | Vaccinology in sub-Saharan Africa |
| title_fullStr | Vaccinology in sub-Saharan Africa |
| title_full_unstemmed | Vaccinology in sub-Saharan Africa |
| title_short | Vaccinology in sub-Saharan Africa |
| title_sort | vaccinology in sub saharan africa |
| url | https://gh.bmj.com/content/4/5/e001363.full |
| work_keys_str_mv | AT helenrees vaccinologyinsubsaharanafrica AT jennifermoisi vaccinologyinsubsaharanafrica AT shabirahmedmadhi vaccinologyinsubsaharanafrica |